STOCK TITAN

QT Imaging Holdings SEC Filings

qti NASDAQ

Welcome to our dedicated page for QT Imaging Holdings SEC filings (Ticker: qti), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

QT Imaging Holdings’ filings rarely read like light bedtime material—dense R&D tables, FDA language, and complex revenue breakouts can stretch past 200 pages. If you have ever searched “QT Imaging Holdings SEC filings explained simply” or wondered why an 8-K suddenly appears after a device-clearance press release, you already know the challenge.

Stock Titan solves this problem. Our AI breaks down each QT Imaging Holdings annual report 10-K simplified into clear sections: R&D spend for next-gen ultrasound, licensing royalties, and backlog of imaging system orders. Need the newest numbers? The platform pulls every QT Imaging Holdings quarterly earnings report 10-Q filing the moment it hits EDGAR and adds plain-English summaries of revenue by segment. Material events such as FDA submissions land as “QT Imaging Holdings 8-K material events explained” notifications, so you never miss a regulatory milestone.

Curious about management’s confidence? Track QT Imaging Holdings insider trading Form 4 transactions in real time. Our dashboards flag patterns like option exercises or clustered sales, while keyword links—“QT Imaging Holdings Form 4 insider transactions real-time” and “QT Imaging Holdings executive stock transactions Form 4”—take you straight to the filings. For governance research, the QT Imaging Holdings proxy statement executive compensation shows pay tied to imaging system sales benchmarks, and AI highlights the metrics that move bonuses.

Whether you are benchmarking R&D efficiency, modeling service-contract margins, or simply understanding QT Imaging Holdings SEC documents with AI, our platform delivers: comprehensive coverage of every form, instant alerts, and expert analysis that turns raw disclosures into actionable clarity.

Rhea-AI Summary

QT Imaging Holdings, Inc. director Taylor Ross was granted 25,000 stock options with an exercise price of $1.90, reported as a Section 16 Form 4 filing. The options were granted on 08/11/2025 and are exercisable for common stock.

Vesting is time-based: one-third vests on August 15, 2026, and the remaining two-thirds vest in eight equal quarterly installments on each November 15, February 15, May 15 and August 15, resulting in full vesting on August 15, 2028, subject to continued service. The report identifies the award as a direct beneficial ownership of 25,000 options.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

QT Imaging Holdings reported an insider grant of 25,000 stock options to John C. Klock Jr., a director and 10% owner. The options were granted on 08/11/2025 with an exercise price of $1.90 and cover 25,000 underlying shares of common stock. The filing indicates the options are held directly and shows an expiration date of 08/11/2035.

The grant vests over time: one-third vests on August 15, 2026, and the remaining two-thirds vest in eight equal quarterly installments each Nov 15, Feb 15, May 15, and Aug 15, becoming fully vested on August 15, 2028, subject to continued service. The Form 4 was signed by Mr. Klock on 08/13/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

QT IMAGING HOLDINGS, INC. [QTIH] reporting person Dr. Avi S. Katz, identified as Chairman and a director, reported an acquisition of 25,000 stock options on 08/11/2025 with an exercise price of $1.90 and an expiration date of 08/11/2035. The filing lists the options as held directly and acquired under Transaction Code "A".

Vesting is defined: one-third vests on August 15, 2026 and the remaining two-thirds vest in eight equal quarterly installments on subsequent November 15, February 15, May 15, and August 15, completing on August 15, 2028, subject to continued service. The form is signed by Dr. Katz on 08/13/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

James S. Greene, a director of QT Imaging Holdings (ticker QTI), was granted 25,000 stock options on 08/11/2025 with an exercise price of $1.90. The options give the right to purchase 25,000 shares of common stock and carry an expiration date of 08/11/2035. The grant vests over time: one-third on August 15, 2026 and the remaining two-thirds in eight equal quarterly installments on each subsequent November 15, February 15, May 15 and August 15, fully vesting on August 15, 2028, subject to continued service. After the reported transaction Mr. Greene directly beneficially owns 25,000 options.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

QT Imaging Holdings, Inc. reporting person Dr. Raluca Dinu, who serves as Chief Executive Officer and a director, was granted 25,000 stock options on 08/11/2025. The options have an exercise price of $1.90 and a stated expiration date of 08/11/2035, and are reported as directly owned following the grant.

The grant vests over roughly three years: one-third vests on August 15, 2026, and the remaining two-thirds vest in eight equal quarterly installments on each November 15, February 15, May 15 and August 15, with full vesting on August 15, 2028, subject to continued service. The award ties management compensation to future equity performance and would create dilution if exercised.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Daniel H. Dickson, a director of QT Imaging Holdings, Inc. (QTI), was granted a stock option to purchase 25,000 shares at an exercise price of $1.90 per share on 08/11/2025. The option is a direct holding, shows an expiration date of 08/11/2035, and is subject to a time-based vesting schedule: one-third vests on August 15, 2026, with the remaining two-thirds vesting in eight equal quarterly installments each November 15, February 15, May 15 and August 15, so the grant will be fully vested on August 15, 2028, contingent on continued service.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

On 21 July 2025, Nasdaq Stock Market LLC filed Form 25 to remove QT Imaging Holdings, Inc. (ticker QTI) common stock from listing and registration under Section 12(b) of the Securities Exchange Act of 1934. The exchange certifies compliance with 17 CFR 240.12d2-2(b) for exchange-initiated delisting and notes that the issuer has satisfied voluntary withdrawal requirements under Rule 12d2-2(c). The notice, signed by Hearings Advisor Aravind Menon, covers only the company’s Common Stock; no financial results, operating updates, or explanatory rationale are provided. Once the SEC processes the filing, QTI shares will cease trading on Nasdaq and the registration will be withdrawn pursuant to the cited rules.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy

FAQ

What is the current stock price of QT Imaging Holdings (qti)?

The current stock price of QT Imaging Holdings (qti) is $0.3951 as of February 7, 2025.

What is the market cap of QT Imaging Holdings (qti)?

The market cap of QT Imaging Holdings (qti) is approximately 10.7M.
QT Imaging Holdings

NASDAQ:QTI

QTI Rankings

QTI Stock Data

10.72M
19.17M
Electromedical & Electrotherapeutic Apparatus
US
NOVATO